First Trust Advisors’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-26,456
Closed -$702K 2533
2021
Q4
$702K Sell
26,456
-56,864
-68% -$1.96M ﹤0.01% 2182
2021
Q3
$3.42M Buy
83,320
+16,492
+25% +$904K ﹤0.01% 1543
2021
Q2
$3.79M Sell
66,828
-7,088
-10% -$262K ﹤0.01% 1518
2021
Q1
$3.1M Buy
73,916
+33,511
+83% +$1.91M ﹤0.01% 1533
2020
Q4
$2.83M Buy
40,405
+9,462
+31% +$389K ﹤0.01% 1400
2020
Q3
$868K Buy
30,943
+22,655
+273% +$738K ﹤0.01% 1825
2020
Q2
$245K Sell
8,288
-30,715
-79% -$803K ﹤0.01% 2192
2020
Q1
$773K Buy
+39,003
New +$984K ﹤0.01% 1756
2019
Q4
Sell
-29,959
Closed -$681K 2402
2019
Q3
$681K Buy
+29,959
New +$742K ﹤0.01% 2011
2019
Q2
Sell
-16,268
Closed -$398K 2445
2019
Q1
$398K Sell
16,268
-13,690
-46% -$310K ﹤0.01% 2210
2018
Q4
$682K Sell
29,958
-92,467
-76% -$2.52M ﹤0.01% 2006
2018
Q3
$3.9M Buy
122,425
+28,596
+30% +$924K 0.01% 1284
2018
Q2
$3.36M Buy
+93,829
New +$3.32M 0.01% 1322

Other funds holding EDIT

First Trust Advisors's EDIT Position: Q1 2022 in Review

First Trust Advisors sold out of Editas Medicine (EDIT) in Q1 2022, closing a stake of 26,456 shares — an estimated $702K sold.

First Trust Advisors first reported a position in EDIT in Q2 2018 and held it in 13 quarters. The position peaked at $3.9M in Q3 2018. 256 funds tracked by Wall St. Rank hold EDIT as of Q1 2022.

  • First Trust Advisors reported no remaining Editas Medicine position as of Q1 2022 after selling out during the quarter.
  • First Trust Advisors sold 26,456 Editas Medicine shares in Q1 2022, an estimated $702K.
  • First Trust Advisors first reported a position in Editas Medicine in Q2 2018 and held it in 13 quarters.
  • First Trust Advisors's Editas Medicine position peaked at $3.9M in Q3 2018.
  • 256 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2022.

Based on First Trust Advisors's 13F filing for Q1 2022, filed 13 May 2022.